Home » New Hair Loss Treatments Pipeline » Allergan Bimatoprost
Detailed information on the research project currently underway. We encourage you to bookmark these pages and check back often. Updates will be added periodically with new information on status, newly-released data, and clinical trial results. Back to New Hair Loss Research Pipeline
Prostaglandins have been shown in studies to be influential in hair follicle cycling. In the treatment of Androgenetic Alopecia, hair follicle cycling means greater number of hairs in growth phase at any given time, resulting in thicker hair.
Bimatoprost is a analogue of the prostaglandin PGF2a. It is hypothesized that it acts on the prostamide receptors in the hair follicles, as well as having a broader biological action. In turn Allergan hopes to establish that Bimatoprost stimulates hair growth and increases pigmentation.
Leading Growth Pharma